Multiple randomised, placebo-controlled trials have tested GLP-1 drugs as add-on therapy to insulin in people with T1D, and the picture that emerges is consistent, if modest: meaningful weight loss, real reductions in daily insulin needs, and improvements in CGM time in range
Regular skin checks and prompt attention to any suspicious growths are essential steps in managing this type of skin cancer
GLP-1 can stimulate pancreatic -cells to release insulin
By contacting, communicating with, or purchasing from this website or other contact methods (including but not limited to phone, forms, email, messaging apps etc.), you confirm your compliance with these conditions and agree to be bound by all associated terms and conditions
Several recently approved indications make it more important than ever to understand the underlying diagnosis
By increasing your skins natural defence against UV rays, Melanotan 2 helps you enjoy outdoor activities with greater peace of mind
